The Journal of Antibiotics · 1992 · 32 citations · 7 references
Life SciencesBiochemistryPharmacologyDrug DiscoveryEnzymologyMetabolismCholesterol BiosynthesisCholesterol MetabolismFatty Acid BiosynthesisLipid BiosynthesisLipid MetabolismSterol MetabolismAcyltransferase ActivityAcyltransferase EnzymesCholesterol EsterificationPharmacological Inhibition Of Cholesterol BiosynthesisTriacylglycerol Biosynthesis
Gliocladium sp. FO-1513 was found to produce novel inhibitors of acyl-CoA: cholesterol acyltransferase (ACAT). Two active compounds, designated glisoprenins A and B, were isolated from the culture broth of the producing strain by a conventional method. The IC50 values of glisoprenins A and B for ACAT activity were 46 and 61 microM in an enzyme assay using rat liver microsomes, and 1.2 and 0.57 microM in a J774 macrophage assay, respectively.
7
Hans‐Otto Kalinowski, Stefan Berger, S. Braun et al. · Analytica Chimica Acta · 1989 · 1.1K citations
Hiroshi Tomoda, Hiroyuki Nishida, Rokuro Masuma et al. · The Journal of Antibiotics · 1991 · 62 citations · Full text